Detalhe da pesquisa
1.
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
Cancer Sci
; 115(5): 1646-1655, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433331
2.
HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity.
Breast Cancer Res Treat
; 201(2): 317-328, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37378696
3.
DNA methylation of the immediate upstream region of BRCA1 major transcription start sites is an independent favorable prognostic factor in patients with high-grade serous ovarian cancer.
Gynecol Oncol
; 167(3): 513-518, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253303
4.
Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents.
Support Care Cancer
; 29(7): 4081-4088, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33404803
5.
Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.
Invest New Drugs
; 38(2): 468-477, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124055
6.
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma.
Oncology
; 98(10): 699-705, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526764
7.
Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study.
Int J Clin Oncol
; 24(9): 1111-1118, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30993482
8.
DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death.
Molecules
; 24(17)2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31480541
9.
Efficacy and Safety of Pazopanib for Recurrent or Metastatic Solitary Fibrous Tumor.
Oncology
; 94(6): 340-344, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29614488
10.
Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma.
Oncology
; 93(3): 177-182, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28521313
11.
The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma.
Int J Gynecol Cancer
; 27(9): 1850-1855, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29040183
12.
Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.
Jpn J Clin Oncol
; 46(4): 370-7, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755829
13.
p53 regulates cytoskeleton remodeling to suppress tumor progression.
Cell Mol Life Sci
; 72(21): 4077-94, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206378
14.
Prophylactic dexamethasone for radiation-induced bone-pain flare.
Lancet Oncol
; 17(2): e39-e40, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26868344
15.
DNA methylation marker to estimate ovarian cancer cell fraction.
Med Oncol
; 39(5): 78, 2022 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195779
16.
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 90(6): 523-529, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289094
17.
Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies.
Cancer Chemother Pharmacol
; 87(1): 53-64, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33146741
18.
Improved survival among patients enrolled in oncology phase 1 trials in recent decades.
Cancer Chemother Pharmacol
; 85(2): 449-459, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745590
19.
Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2.
Cell Adh Migr
; 12(2): 101-108, 2018 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28686514
20.
Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lung.
Oncol Rep
; 39(3): 1148-1154, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29328464